戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 irch pollen or grass pollen) or placebo (ALK diluent).
2  oligonucleotides and mercaptohexanol as the diluent.
3 st of the protein, whereas flow provides the diluent.
4 with recombinant murine IL-18 or the control diluent.
5 tissue lysis buffer (Roche), as the specimen diluent.
6 s were discovered in the bovine sera used as diluent.
7 ank the same final concentration of the DMSO diluent.
8 re MnSOD-BP activity than cells treated with diluent.
9                Dextran 70 (6%) was used as a diluent.
10 en delivery significantly when compared with diluent.
11                Dextran 70 (6%) was used as a diluent.
12 (0.6 nmol in 5 microl) or an equal volume of diluent.
13 tions with either saline or the cyclosporine diluent.
14 anionic vesicles and to zwitterionic neutral diluent.
15 0 BU/mL (4.87 mug/mL Fel d1), P < 0.0001 vs. diluent.
16 contains a difunctional epoxide and reactive diluent.
17 sed, for both methyl and hydroxyl terminated diluent.
18 ated bitumen pathway, which does not require diluent.
19 d forms of Dryvax vaccine, with any of the 3 diluents.
20 2; a control group received only the vaccine diluents.
21 erified cholesterol were essentially neutral diluents.
22 tration of intravenous bumetanide in various diluents.
23 -MAN) and ethylene-glycol-terminated (C6-EG) diluents.
24  rotating membrane cell technique in several diluents.
25 ed in utero with fragments of PTHrP, PTH, or diluent 1 h before administering 45Ca and 51Cr to the da
26 layers containing a short alkylthiol surface diluent [11-mercapto-1-undecanol (MCU)] on gold supports
27  an atraumatic injection technique, isotonic diluent, a low-infusion pressure, and a small injection
28                In the presence of water as a diluent, a significant fraction of the nitrosoamide was
29 tion delivered through the nebulizer and the diluent air flow rate.
30 ixture of a ferrocene OPV methyl thiol and a diluent alkanethiol were deposited on gold.
31 ntralesional injections of 2000 IU of hCG or diluent alone (6 patients each; two lesions per patient)
32 e received 50, 100, or 200 ng of IL-13-PE or diluent alone (i.e., control group) on alternate days fr
33 ant porcine TNF-alpha (n = 7) and pigs given diluent alone (n = 7).
34  (minimum 10 mol/L+/-20% cells; N=78) or (2) diluent alone (N=83), via intracoronary infusion.
35 roximately 35% relative to animals receiving diluent alone (P < 0.05).
36 m adult donors were treated with T-oligos or diluent alone for 24 h, then UVB- or sham-irradiated, an
37 fibroblasts were pretreated with T-oligos or diluent alone for 24 h, UV-irradiated, and processed for
38 phorylated 9 base oligonucleotide (p9mer) or diluent alone for 48 h, then UV-irradiated with solar-si
39 ed once with thymidine dinucleotide (pTT) or diluent alone or UV-irradiated.
40 Explants treated with pTT or UV but not with diluent alone showed initial inhibition of epidermal pro
41                                  Compared to diluent alone, pTT or UV pretreatment decreased the numb
42  tumor implants compared with treatment with diluent alone.
43 ere injected, two with the drug and one with diluent alone.
44 patients with mild allergic asthma underwent diluent and allergen inhalation challenges.
45 nged in a loop to drive cyclic mixing of the diluent and carryover, and two bus valves to control flu
46 NF-alpha), we examined sphingosine levels in diluent and TNF-alpha-stimulated cardiac myocytes.
47  kinetic model derived with D-enantiomers as diluents and also that D-phospholipids bind to the enzym
48 diluent (original Dryvax diluent, new Dryvax diluent, and phosphate-buffered saline), and temperature
49 yl) phosphate as the extractant in a heptane diluent, and studied its efficacy for REE recovery as a
50 ternal standard curve and need for calibrant diluent, and takes into account the individual matrix in
51 detected immediately after UV irradiation in diluent- and T-oligo-treated skin, but CPDs were strikin
52 apoptotic epidermal cells were comparable in diluent- and T-oligo-treated skin.
53 rradiated skin and for 24 h after UV in both diluent- and T-oligo-treated specimens.
54            The third group received only the diluent as a placebo.
55       Control pigs were sham-inoculated with diluent at 3 days of age.
56       The effects of time, viral dose, viral diluent buffer volume, and dexamethasone on expression o
57 o provides a way of looking at the uptake of diluents by glasses described by case II and super case
58 s used in this study, the methoxy-terminated diluent (C6-MEG) is the most effective in alleviating bo
59 atically evaluated the effect of passivating diluent chain length on the overall sensor performance.
60 llergen stimulation; no changes were seen on diluent challenge day.
61 IL-17A, and IL-33 were unchanged compared to diluent challenge.
62 sonal allergic rhinitis underwent a control (diluent) challenge followed by NAC after an interval of
63 halan hydrochloride (40 microg in 0.04 mL of diluent) combined with topotecan hydrochloride (8-20 mic
64                       The use of TEGDMA as a diluent comonomer in the formulation of hydrophobic adhe
65 ants were independent of the identity of the diluent component of the mixed monolayer, and using an u
66            Analysis of the substrate and the diluent concentration dependence of the rate of hydrolys
67 -incubated with tirilazad mesylate than with diluent control (91.8% +/- 4.6% versus 39.3% +/- 7.1%; P
68 ethanolic extract of PC-SPES compared with a diluent control [ethanol < or = 0.3% (v/v)].
69 euptake inhibitor (SSRI) antidepressant; and diluent control for 28days via drinking water.
70 fects at 200 nM and a maximal increase above diluent control of 148% +/- 2% at 20 microM.
71 oups of 6 animals each that received vehicle diluent control or rhIL-15 at 10, 20, or 50 mug/kg/d IV
72 Sprague-Dawley rats received an injection of diluent (control [C]) or streptozotocin 65 mg/kg (DM) an
73 ith TAC, SIR, and combination of TAC-SIR, or diluent (control) for 4 weeks.
74 ects of 24-hour infusions of PGN, LT, ET, or diluent (control) on coagulation measures 6, 24, or 48 h
75 , its metabolite lysophosphatidylcholine, or diluent (control).
76                         However, compared to diluent controls, at 48 and 72 h T-oligos significantly
77                  We find that the vitrifying diluent does not adversely affect device performance.
78         These observations indicate that the diluent does not participate in the electron-transfer ev
79 vated at 5 min after challenge (P < 0.05 vs. diluent); eotaxin, IL-4, -5, -9, and -13 were increased
80 32)P-radiometric assays as a function of MCU diluent exposure.
81 ightforwardly controlled by the macromonomer/diluent feed ratio.
82 ach dilution process, which is composed of a diluent flush cycle followed by a mixing cycle, is carri
83 monkeys with GH, IGF-I, GH + IGF-I or saline diluent for 7 weeks.
84 hosphocholine (D-LPC) is an adequate neutral diluent for bvPLA2, which is defined as an amphiphile th
85 her 14 kDa phospholipases A2 are not neutral diluents for bvPLA2.
86  employing D-enantiomers of phospholipids as diluents for characterizing surface kinetics of lipid hy
87 of bvPLA2 include the following: (1) Neutral diluents for other 14 kDa phospholipases A2 are not neut
88 e controls included 2AxMCM mice treated with diluents for tamoxifen and tamoxifen-treated MCM litterm
89 sis and application of three new antifouling diluents for the fabrication of an E-PB HIV sensor.
90 receptor antagonist, losartan (30 mg/kg), or diluent from 4 to 8 weeks of age.
91 effect on plasma FSH concentrations, and the diluent had no effect on either plasma FSH or LH.
92 tuses, but PTHrP-(1-34), PTH-(1-84), and the diluent had no effect.
93 12 lesions in the six patients injected with diluent had responses, as compared with 10 of the 12 les
94 ixed monolayer, and using an unsaturated OPE diluent has no effect on the rate of electron transfer t
95 ortantly, incorporation of these antifouling diluents has negligible impact on other important sensor
96 each passivated with a different alkanethiol diluent, have been demonstrated to be sensitive; the lim
97    As the disparity between macromonomer and diluent homopolymerization rates increases, the reactivi
98  skin) in response to allergen compared with diluent in allergics.
99 omplexes in the organic phase when used as a diluent in extraction studies of univalent ions.
100 rHb1.1 resuscitation was more effective than diluent in improving systemic and regional hemodynamics
101 particles (AuNPs), utilizing DNA linkers and diluents in place of traditional self-assembled monolaye
102                                          MCU diluent incorporation into HS-ssDNA monolayers initially
103 n hepcidin (50 microg/mouse), but not of its diluent, induced hypoferremia within 4 hours.
104 ormed in 24 atopic subjects at allergen- and diluent-injected sites before 6 and 48 h after, three in
105   Our results show that the use of a shorter diluent like 2-mercaptoethanol is more advantageous than
106  aggregate to which enzyme binds but neutral diluent molecules bind weakly in the enzyme's active sit
107 orm for the catalytic turnover; however, the diluent molecules have poor affinity for the active site
108 e interaction between the S-NB and L-NB with diluent molecules in the mixed SAMs.
109  were formed between AQ moieties of L-NB and diluent molecules terminated by hydroxyl group within a
110 r three doses; n = 11) or placebo containing diluent (n = 10).
111 ither human rIL-10 (n = 3, 500 microg/kg) or diluent (n = 3).
112  and diluted 1:10), diluent (original Dryvax diluent, new Dryvax diluent, and phosphate-buffered sali
113 ant contribution of NMHCs in the high-purity diluent nitrogen used in their preparation, the relative
114 ion strands can be tailored using coadsorbed diluent oligonucleotides.
115 ed DNA monolayers, as well as effects of MCU diluent on DNA hybridization in complex milieu (i.e., se
116 M can be delayed (compared with insulin-free diluent, once daily, n = 8) with equivalent efficiency b
117 t mice when compared to animals treated with diluent only (7 vs 26%, P=0.0079).
118 actor receptor, and 10 were treated with the diluent only as control rats.
119 ty plasmids alone, donor hearts treated with diluent only, and untransplanted native hearts.
120 ive to recipients previously pretreated with diluent only.
121 nge 0.243 to 14.6 mug/mL Fel d1, and matched diluent-only provocation.
122 after 24 to 48 h, whereas cells treated with diluent or sense oligonucleotides maintained tight perin
123 ted with chronic infusion pumps and received diluent or three doses of IL-1 infused subcutaneously fo
124     Osmotic infusion pumps containing either diluent or TNF-alpha were implanted into the peritoneal
125 were treated with either intravenous saline (diluent) or AR-R 17477 (1 or 3 mg/kg) 30 mins before or
126  (undiluted, diluted 1:5, and diluted 1:10), diluent (original Dryvax diluent, new Dryvax diluent, an
127 cells increased in both groups compared with diluent (P = 0.02 and 0.03 for both TFs), whereas only C
128 s suggest that copolymerizing a macromonomer/diluent pair with evenly matched self-propagation rate c
129 ecombinant human hemoglobin (rHb1.1), rHb1.1 diluent (phosphate buffered saline) resuscitation of hem
130        rHb1.1 (1 g/kg body weight) or rHb1.1 diluent (phosphate buffered saline, 36 mL/kg body weight
131 autologous CD34+ cells or an equal volume of diluent (placebo).
132 ith vector but not CID (P < 0.035) or vector-diluent plus CID (P < 0.022), both of which grew more ra
133                       In pTT- and UV- versus diluent-pretreated explants, the rate of CPD removal was
134 ed p53 protein was increased in T-oligo- vs. diluent-pretreated skin at the time of irradiation, and
135 ounterions (Co(350)(ClO(4))(2)) and no other diluent provides charge transport rates from the oxidati
136 onomer and a discrete norbornenyl comonomer (diluent) provides opportunities to control the backbone
137  20+/-9% and 15+/-11% remained after 24 h in diluent, pTT and p9mer treated cells, respectively.
138 cate a wide range of accessible macromonomer/diluent reactivity ratios (0.08 < r1/r2 < 20), correspon
139  room temperature, regardless of dilution or diluent, resulted in a significantly greater decrease in
140 kin, kidney, spleen, and heart compared with diluent resuscitation.
141 ine and rail pathway, and the dilbit without diluent return scenario has an additional heated bitumen
142 thetic crude oil and dilbit with and without diluent return) in which 750000 bpd of Alberta's bitumen
143     Differences in K(i) between allergen and diluent segments were compared with those in cell counts
144  together with the WHO reference reagent and diluent serum.
145 feature suggests that TEGDMA is an excellent diluent, since it increases the mobility of the reacting
146 s are highly tailorable via incorporation of diluents, solvents, nanoparticles, or polymers, or the a
147 erence being that ASM allows toggling of the diluent stream during each (2)D separation cycle.
148 ous than using a longer and more passivating diluent such as 6-mercapto-1-hexanol.
149                          Thus POPG acts as a diluent surface to which the lipase binds in an active,
150 mes-is the incorporation of a glass-inducing diluent that enables controlled crystallization from an
151           The small-molecule diesters act as diluents that increase the average distance between graf
152 d rate of tumor growth (P<0.01 compared with diluent treated controls).
153 emoved thymine dimers at least as rapidly as diluent treated newborn cells, demonstrating that pTT an
154 ted animals had a higher mortality rate than diluent-treated animals and a 10-fold elevation in trans
155 ge profile in response to I/R was similar to diluent-treated animals, and endothelial cell adhesion m
156  molecules in the KC-depleted animals versus diluent-treated animals.
157 fibroblasts and keratinocytes, compared with diluent-treated cells.
158 rs were increased to a level greater than in diluent-treated control mice and approached or equaled t
159  somatostatin (-59%, P = 0.02) compared with diluent-treated controls.
160 nset of IDDM (n = 8, P = 0.25) compared with diluent-treated controls.
161 d LDH release by hypoxic cells compared with diluent-treated hypoxic cells.
162 alveolar lavage fluid compared with those in diluent-treated or control peptide-treated mice.
163 UV-induced DNA damage, explants were pTT- or diluent-treated or UV-irradiated.
164 there was no effect on these hormones in the diluent-treated patients.
165 CPDs were strikingly reduced in T-oligo- vs. diluent-treated skin at 24, 48, and 72 h.
166                                Compared with diluent-treated tumor-bearing mice, intratumoral injecti
167 d IL-12 and reduced levels of IL-10 than did diluent-treated tumor-bearing mice.
168 he nasal mucosa of AR animals, compared with diluent treatment.
169 increased at 8 h (P < 0.05 to P < 0.0001 vs. diluent); TSLP was undetectable; IL-10, IL-17A, and IL-3
170 usly with recombinant human IL-11 or control diluent twice daily, from 2 days before BMT to 7 days af
171 CO2e/MJ, respectively, showing the effect of diluent use on fuel emissions.
172 de increased urine volume, regardless of the diluent used.
173        Among the three thiolated antifouling diluents used in this study, the methoxy-terminated dilu
174 re compared with the right upper lobe, where diluent was applied as a control.
175 between the AQ moiety and the surface of the diluent was increased, for both methyl and hydroxyl term
176 ic agents or an equivalent volume of placebo diluents was administered 10 mins after restoration of s
177   The ratio of eosinophil count (allergen to diluent) was linearly related (R(2) = 0.9917, P < 0.001)
178 ntrol, the homopolymerization kinetics of 23 diluents were studied, representing diverse variations i
179 f airway immune cells from a large volume of diluent, which was not readily possible in the single-pa
180 ring and injecting cells individually into a diluent with a micromanipulator is time-consuming.
181 hieved through copolymerizations of selected diluents with a poly(d,l-lactide) (PLA), polydimethylsil

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top